BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15582892)

  • 1. [The surgical management of recurrent urological malignancies after primary ablative therapy].
    Galiano M; Dugardin F; Rozet F; Cathelineau X; Vallancien G
    Bull Cancer; 2004 Nov; 91(11):875-81. PubMed ID: 15582892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of recurrent genitourinary malignancies.
    Greenberg RE; Charles RS; Samaha AM; Chelsky M; Rosen S
    Semin Oncol; 1993 Oct; 20(5):473-92. PubMed ID: 8211196
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urological cancer].
    Kato M; Higashihara E
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1255-9. PubMed ID: 16184920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Essays on surgical oncourology].
    Davydov MI; Matveev VB; Volkova MI
    Vestn Ross Akad Med Nauk; 2008; (10):39-45. PubMed ID: 19140397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous laparoscopic management of 3 urological malignancies.
    Deng DY; Meng MV; Grossfeld GD; Stoller ML
    J Urol; 2002 May; 167(5):2125-6. PubMed ID: 11956456
    [No Abstract]   [Full Text] [Related]  

  • 6. [Laparoscopic surgery in urologic oncology].
    Vallancien G; Cathelineau X; Barret E; Rozet F
    Bull Acad Natl Med; 2007 Oct; 191(7):1367-73; discussion 1373-4. PubMed ID: 18447058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of provider volume on outcomes from urological cancer therapy.
    Joudi FN; Konety BR
    J Urol; 2005 Aug; 174(2):432-8. PubMed ID: 16006859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery for the urinary tract cancer.
    Lukkarinen O
    Ann Chir Gynaecol; 1996; 85(3):202-6. PubMed ID: 8950440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of radical procedures for urologic cancer.
    Garrett JE; Rowland RG
    Surg Oncol Clin N Am; 2005 Jul; 14(3):553-68, vii. PubMed ID: 15978429
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: current status.
    Matin SF
    BJU Int; 2005 Mar; 95 Suppl 2():68-74. PubMed ID: 15720338
    [No Abstract]   [Full Text] [Related]  

  • 12. Robotic salvage retropubic prostatectomy after radiation/brachytherapy: initial results.
    Kaouk JH; Hafron J; Goel R; Haber GP; Jones JS
    BJU Int; 2008 Jul; 102(1):93-6. PubMed ID: 18410443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
    Ward JF
    Eur Urol; 2010 Mar; 57(3):444-5. PubMed ID: 19303198
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
    Patel A
    Eur Urol; 2010 Mar; 57(3):444. PubMed ID: 19303196
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indication and limitation of endoscopic surgery against urological cancer].
    Kondo Y; Nishimura T
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1501-5. PubMed ID: 15508440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival.
    Bourgade V; Drouin SJ; Yates DR; Parra J; Bitker MO; Cussenot O; RouprĂȘt M
    World J Urol; 2014 Apr; 32(2):475-9. PubMed ID: 23455886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy.
    Nguyen CT; Lane BR; Kaouk JH; Hegarty N; Gill IS; Novick AC; Campbell SC
    J Urol; 2008 Jul; 180(1):104-9; discussion 109. PubMed ID: 18485401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of isolated renal fossa recurrence following radical nephrectomy.
    Master VA; Gottschalk AR; Kane C; Carroll PR
    J Urol; 2005 Aug; 174(2):473-7; discussion 477. PubMed ID: 16006867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.